University Research Lecturer
Helen Dakin joined the Health Economics Research Centre in February 2008. Before starting at HERC, she worked at Abacus International and completed her MSc in Economic Evaluation in Healthcare at City University. She previously graduated from Cambridge University with Masters and Bachelor's degrees in Biochemistry. In 2014, she completed a DPhil at the University of Oxford on the optimal methods for conducting economic evaluations of factorial clinical trials.
Her current projects include: the STAR trial, which evaluates radiotherapy alongside bevacizumab (Avastin) in age-related macular degeneration; the ACHE study, which evaluates clinical tools and thresholds for selecting patients for joint replacement; and the KAT trial, which assesses the cost-effectiveness of different types of knee replacement component.
Research paper on factors influencing NICE decisions available here.
Cost-effectiveness of Replacing Versus Discarding the Nail in Children with Nail Bed Injury
Dakin HA. et al, (2023), British Journal of Surgery
Effectiveness of nail bed repair in children with or without replacing the fingernail: the NINJA multicentre randomised controlled trial
JAIN A. et al, (2023), British Journal of Surgery
Cost-effectiveness of adalimumab for early-stage Dupuytren's disease : an economic evaluation based on a randomized controlled trial and individual-patient simulation model.
Dakin H. et al, (2022), Bone Jt Open, 3, 898 - 906
Cost-utility analysis of surgical fixation with Kirschner wire versus casting after fracture of the distal radius : a health economic evaluation of the DRAFFT2 trial.
Png ME. et al, (2022), Bone Joint J, 104-B, 1225 - 1233
Corrigendum: Progressive exercise compared with best-practice advice, with or without corticosteroid injection, for rotator cuff disorders: the GRASP factorial RCT.
Hopewell S. et al, (2022), Health Technol Assess, 25, 159 - 160